References :
  1. Dodge JA, Lewis PA, Stanton M, Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 2007; 29: 522-6.
  2. Cohen-Cymberknoh M, Shoseyov D, Kerem E. Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life.Am J Respir Crit Care Med 2011; 183: 1463-71.
  3. Courtney JM, Bradley J, McCaughan J, O’Connor TM, Shortt C, Bredin CP, Bradbury I, Elborn JS. Predictors of mortality in adults with cystic fibrosis. Paediatr Pulmonol 2007; 42: 525-32.
  4. Corey M, Edwards L, Levison H, Knowles M. Longitudinal analysis of pulmonary function declines in patients with cystic fibrosis. J Pediatr 1997; 131: 809–14.
  5. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis.N Engl J Med 1992; 326: 1187-91.
  6. de Jong PA, Lindblad A, Rubin L, Hop WC, de Jongste JC, Brink M,  Tiddens H A W M. Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis.Thorax 2006; 61: 80-5.
  7. Gustafsson PM, Aurora P, Lindbland A. Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis. Eur Respir J 2003; 22: 972-9.
  8. Ellemunter H, Fuchs SI, Unsinn KM, Freund MC, Waltner-Romen M, Steinkamp G, Gappa M. Sensitivity of Lung Clearance Index and chest computed tomography in early CF lung disease.Respir Med 2010; 104: 1834-42.
  9. Stanojevic S, Davis SD, Retsch-Bogart G, Webster H, Davis M, Johnson RC, Jensen R, Pizarro ME, Kane M, Clem CC, et al. Progression of Lung Disease in Preschool Patients with Cystic Fibrosis.Am J Respir Crit Care Med 2017; 195: 1216-25.
  10. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation consensus panel.J Pediatr 1998; 132: 589-95.
  11. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Griten CPM, Gustafsson P, et al. Standardisation of spirometry.Eur Respir J 2005; 26: 319-38.
  12. Robinson PD, Latzin P, Verbanck S, Hall GL, Horsley A, Gappa M, Thamrin C, Arets HGM, Aurora P, Fuchs SI, et al. Consensus statement for inert gas washout measurement using multiple- and single-breath tests. Eur Respir J 2013; 41: 507–22.
  13. Brody AS, Klein JS, Molina PL, Quan J, Bean JA, Wilmott RW. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests.J Pediatr 2004; 145: 32-8.
  14. Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.J Cyst Fibros 2003; 2: 29-34
  15. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-7.
  16. Gibbons WJ, Fruchter N, Sloan S, Levy RD. Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years.J Cardiopulm Rehabil 2001; 21: 87-93.
  17. Geiger R, Strasak A, Treml B, Gasser K, Kleinsasser A, Fischer V, Geiger H, Loeckinger A, Stein JI. Six-minute walk test in children and adolescents.J Pediatr 2007; 150: 395-9.
  18. Sly PD, Brennan S, Gangell C, de Klerk N, Murray C, Mott L, Stick SM, Robinson PJ, Robertson CF, Ranganathan SC, et al. Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med. 2009;180:146-52.
  19. Tiddens HA. Detecting early structural lung damage in cystic fibrosis.Pediatr Pulmonol 2002; 34: 228-31
  20. Lum S, Gustafsson P, Ljungberg H, Hülskamp G, Bush A, Carr SB, Castle R, Hoo AF, Price J, Ranganathan S, et al. Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests. Thorax 2007; 62: 341-7.
  21. Belessis Y, Dixon B, Hawkins G, Pereira J, Peat J, MacDonald R, Field P, Numa A, Morton J, Lui K, et al. Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index.Am J Respir Crit Care Med 2012; 185: 862-73.
  22. Nguyen TT, Thia LP, Hoo AF, Bush A, Aurora P, Wade A, Chudleigh J, Lum S, Stocks J, London Cystic Fibrosis Collaboration (LCFC). Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants. Thorax 2014; 69: 910–7.
  23. Ramsey KA, Rosenow T, Turkovic L, Skoric B, Banton G, Adams AM, Simpson SJ, Murrsy C, Ranganathan SC, Stick SM, et al. Lung Clearance Index and Structural Lung Disease on Computed Tomography in Early Cystic Fibrosis.Am J Respir Crit Care Med 2016; 193: 60-7.
  24. Subbarao P, Stanojevic S, Brown M, Jensen R, Rosenfeld M, Davis S, Brumback L, Gustafsson P, Ratjen F. Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline. Am J Respir Crit Care Med 2013; 188: 456–60.
  25. Rayment JH, Stanojevic S, Davis SD, Retsch-Bogart G, Ratjen F. Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis.Thorax 2018; 73: 451–8.
  26. Ratjen F, Klingel M, Black P, Powers MR, Grasemann H, Solomon M, Sagel SD, Donaldson SH, Rowe SM, Rosenfeld M. Changes in Lung Clearance Index in Preschool-aged Patients with Cystic Fibrosis treated with Ivacaftor (GOAL): A Clinical Trial.Am J Respir Crit Care Med 2018; 198: 526-8.
  27. Aurora P, Bush A, Gustafsson P, Oliver C, Wallis C, Price J, Stroobant J, Carr S, Stocks J, London Cystic Fibrosis Collaboration. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med 2005; 171: 249–56.
  28. Singer F, Kieninger E, Abbas C, Yammine S, Fuchs O, Proietti E, Regamey N, Casaulta C, Frey U, Latzin P. Practicability of nitrogen multiple-breath washout measurements in a pediatric cystic fibrosis outpatient setting.Pediatr Pulmonol 2013; 48: 739-46.
  29. Loeve M, Krestin GP, Rosenfeld M, de Bruijne M, Stick SM, Tiddens HA. Chest computed tomography: a validated surrogate endpoint of cystic fibrosis lung disease? Eur Respir J 2013; 42: 844–57.
  30. Szczesniak R, Turkovic L, Andrinopoulou ER, Tiddens HAWM. Chest Imaging in CF Studies: What Counts, and Can be Counted?J Cyst Fibros 2017; 16: 175-85.